Editas Medicine, Inc. Balance Sheet
EDIT|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Editas Medicine, Inc. had $187M in total assets and $134M in shareholders' equity as of FY2025. Total debt was $54M against $147M in cash, resulting in a $93M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146.6M | $131.5M | $141.5M | $141.5M | $203.5M | $139.7M | $238.2M | $146.6M |
| Current Assets | $163.9M | $289.3M | $340.8M | $356.8M | $507.3M | $419.1M | $463.8M | $374.8M |
| PP&E (Net) | $3.5M | $14.5M | $12.0M | $15.6M | $17.1M | $14.0M | $10.9M | $40.2M |
| Total Assets | $186.5M | $341.6M | $499.2M | $514.3M | $677.5M | $572.6M | $508.9M | $420.4M |
| Current Liabilities | $46.2M | $77.2M | $63.2M | $60.1M | $46.9M | $58.2M | $60.0M | $35.9M |
| Total Debt | $53.6M | $52.4M | - | - | - | - | - | - |
| Shareholders' Equity | $134.3M | $349.1M | $553.6M | $393.6M | $262.4M | $236.2M | $208.1M | $134.6M |